{
    "clinical_study": {
        "@rank": "30192", 
        "arm_group": [
            {
                "arm_group_label": "computer-based reminders and alerts", 
                "arm_group_type": "Active Comparator", 
                "description": "Behavioral: display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts (decision support in potassium-inc. drug-drug-interactions)"
            }, 
            {
                "arm_group_label": "no computer-based reminders or alerts", 
                "arm_group_type": "No Intervention", 
                "description": "Behavioral: no display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate the impact of reminders for serum potassium monitoring and of hyperkalemia\n      alerts during potassium-increasing drug-drug-interactions."
        }, 
        "brief_title": "Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hyperkalemia", 
        "condition_browse": {
            "mesh_term": "Hyperkalemia"
        }, 
        "detailed_description": {
            "textblock": "The development of hyperkalemia during potassium-increasing drug-drug-interactions (DDIs) is\n      associated with (i) unknown or elevated serum potassium level at onset of treatment and (ii)\n      insufficient monitoring of serum potassium during therapy. However, potassium-increasing\n      DDIs are frequently started despite an unknown or elevated serum potassium level, and\n      monitoring intervals often exceed 48 hours.\n\n      This study investigates the impact of reminders for serum potassium monitoring and\n      hyperkalemia alerts. Both reminders and alerts are displayed in the electronic patient chart\n      of in-patients treated with potassium-increasing DDIs."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  in-patients treated with concurrent potassium-increasing drugs\n\n        Exclusion criteria:\n\n          -  outpatients; in-patients on wards without computerized physician order entry (i.e.\n             patients treated in the ICU)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020317", 
            "org_study_id": "FZMI-KEK-ZH-Nr. 2013"
        }, 
        "intervention": {
            "arm_group_label": "computer-based reminders and alerts", 
            "description": "display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts", 
            "intervention_name": "decision support in potassium-inc. drug-drug-interactions", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "drug interactions", 
            "Drug Monitoring", 
            "Potassium", 
            "Hyperkalemia"
        ], 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions", 
        "overall_contact": {
            "email": "emmanuel.eschmann@usz.ch", 
            "last_name": "Emmanuel Eschmann, MD"
        }, 
        "overall_contact_backup": {
            "email": "juerg.blaser@usz.ch", 
            "last_name": "Juerg Blaser, PhD, Prof"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics", 
            "last_name": "Juerg Blaser, PhD, Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Rate of serum potassium monitoring intervals of < = 72 hours during potassium-increasing drug-drug-interactions in proportion to all serum potassium monitoring intervals during potassium-increasing drug-drug-interactions", 
            "measure": "Impact on serum potassium monitoring during potassium-increasing drug-drug-interactions", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "reference": [
            {
                "PMID": "24150532", 
                "citation": "Eschmann E, Beeler PE, Kaplan V, Schneemann M, Z\u00fcnd G, Blaser J. Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug-drug interactions. Eur J Clin Pharmacol. 2013 Oct 23. [Epub ahead of print]"
            }, 
            {
                "PMID": "23920830", 
                "citation": "Eschmann E, Beeler PE, Z\u00fcnd G, Blaser J. Evaluation of alerts for potassium-increasing drug-drug-interactions. Stud Health Technol Inform. 2013;192:1056."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020317"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Frequency of hyperkalemia during potassium-increasing drug-drug-interactions", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Frequency of potassium-increasing drug-drug-interactions ordered in the presence of hyperkalemia", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Frequency of transfers to the ICU during potassium-increasing drug-drug-interactions in function of the serum potassium level", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Frequency of death during potassium-increasing drug-drug-interactions in the presence or absence of hyperkalemia", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Change in frequency distribution of serum potassium monitoring intervals", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Response of physicians to the computer-based alerts and reminders", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}